9219 related articles for article (PubMed ID: 15327103)
1. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.
Augsburger JJ; Schneider S; Narayana A; Breneman JC; Aron BS; Barrett WL; Trichopoulos N
Can J Ophthalmol; 2004 Jun; 39(4):380-7. PubMed ID: 15327103
[TBL] [Abstract][Full Text] [Related]
2. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension.
Pach JM; Robertson DM; Taney BS; Martin JA; Campbell RJ; O'Brien PC
Am J Ophthalmol; 1986 Mar; 101(3):325-31. PubMed ID: 3953727
[TBL] [Abstract][Full Text] [Related]
4. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
Gray ME; Corrêa ZM; Augsburger JJ; Barrett W
Int Ophthalmol; 2007 Aug; 27(4):273-6. PubMed ID: 17468833
[TBL] [Abstract][Full Text] [Related]
5. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.
Augsburger JJ; Schneider S; Freire J; Brady LW
Graefes Arch Clin Exp Ophthalmol; 1999 Jul; 237(7):558-67. PubMed ID: 10424306
[TBL] [Abstract][Full Text] [Related]
6. Early-onset scleral necrosis after iodine I 125 plaque radiotherapy for ciliochoroidal melanoma.
Corrêa ZM; Augsburger JJ; Freire J; Eagle RC
Arch Ophthalmol; 1999 Feb; 117(2):259-61. PubMed ID: 10037576
[TBL] [Abstract][Full Text] [Related]
7. Extrascleral extension in association with ciliochoroidal melanoma: ultrasound biomicroscopy with histopathological correlation.
Noble J; Qazi FA; Lakosha HK; Simpson ER; Yucel Y; McGowan H; Pavlin C; Altomare F
Can J Ophthalmol; 2005 Oct; 40(5):616-8. PubMed ID: 16391627
[TBL] [Abstract][Full Text] [Related]
8. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
9. Safety of pars plana vitrectomy in eyes with plaque-irradiated posterior uveal melanoma.
Bansal AS; Bianciotto CG; Maguire JI; Regillo CD; Shields JA; Shields CL
Arch Ophthalmol; 2012 Oct; 130(10):1285-90. PubMed ID: 23044941
[TBL] [Abstract][Full Text] [Related]
10. Extrascleral extension of choroidal melanoma after iodine-125 brachytherapy treatment: a case series.
Mustak H; Lo C; Cohen LM; Tran A; Almanzor R; McCannel TA; Goldberg RA; Rootman DB
Eye (Lond); 2023 Feb; 37(2):249-255. PubMed ID: 34987200
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy.
Karlsson UL; Augsburger JJ; Shields JA; Markoe AM; Brady LW; Woodleigh R
Ophthalmology; 1989 Mar; 96(3):382-8. PubMed ID: 2710530
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
Lommatzsch PK; Werschnik C; Schuster E
Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
[TBL] [Abstract][Full Text] [Related]
14. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
15. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
16. [Local, regional and systemic dissemination of choroidal melanoma : Clinical and pathological correlation from 2 cases].
Martel A; Lassalle S; Gastaud L; Maschi C; Caujolle JP; Nahon-Esteve S
J Fr Ophtalmol; 2019 Oct; 42(8):834-838. PubMed ID: 31196663
[TBL] [Abstract][Full Text] [Related]
17. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
18. Enucleation versus preservation of blind eyes following plaque radiotherapy for choroidal melanoma.
Augsburger JJ; Khouri L; Roumeliotis A; Kersten RC; Kulwin DR; Schneider S
Can J Ophthalmol; 2004 Jun; 39(4):372-9. PubMed ID: 15327102
[TBL] [Abstract][Full Text] [Related]
19. Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension.
Hykin PG; McCartney AC; Plowman PN; Hungerford JL
Br J Ophthalmol; 1990 Jan; 74(1):36-9. PubMed ID: 2106340
[TBL] [Abstract][Full Text] [Related]
20. Massive orbital extension of posterior uveal melanomas.
Shields JA; Shields CL
Ophthalmic Plast Reconstr Surg; 1991; 7(4):238-51. PubMed ID: 1764421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
